Purple Biotech Ltd.

PPBT chart

Purple Biotech Ltd. news

• Enterprise value to EBIT forward of Purple Biotech Ltd. Sponsored ADR – MUN:1YI0

  TradingView · Oct 26, 4:40 PM EDT

• Purple Biotech Ltd. Estimates – TASE:PPBT

  TradingView · Oct 24, 11:13 PM EDT

• Top Midday Gainers

  Yahoo Finance · Sep 2, 1:50 PM EDT

• Purple Biotech U.S. Patent Allowance Strengthens CAPTN-3 Multispecific Antibody Protection

  investorshub.advfn.com · Sep 2, 11:07 AM EDT

• New U.S. Patent Allowance Strengthens Protection for CAPTN-3 Modular Platform for Next-Generation Multispecific Antibodies

  Yahoo Finance · Sep 2, 7:30 AM EDT

• Purple Biotech Reports Second Quarter 2026 Financial Results

  Yahoo Finance · Aug 7, 7:00 AM EDT

• Purple Biotech Presents New IM1240 Preclinical Data Showing Anti-Tumor Activity and Broad Therapeutic Window (PPBT)

  investorshub.advfn.com · Jun 11, 10:38 AM EDT

• Purple Biotech Presents New Preclinical Data at EACR 2026 Highlighting IM1240's Anti-Tumor Activity, Favorable Safety and Pharmacokinetic Profile, and Broad Therapeutic Window

  Yahoo Finance · Jun 11, 7:00 AM EDT

• Purple Biotech Reports First Quarter 2026 Financial Results and Business Highlights

  Yahoo Finance · May 15, 7:00 AM EDT

• Purple Biotech Announces New Data from CAPTN-3 Platform Tri-specific IM1240

  Yahoo Finance · Apr 27, 7:00 AM EDT

• Purple Biotech Establishes Scientific Advisory Board to Support Development of CAPTN-3 Tri-Specific Antibody Platform

  Yahoo Finance · Apr 23, 7:00 AM EDT

• Purple Biotech Achieves Toxicology Milestone Demonstrating an Expanded Therapeutic Window for CAPTN-3 Platform Tri-specific Antibody, IM1240

  Yahoo Finance · Jan 7, 8:00 AM EST

Purple Biotech Ltd. key financials

No XBRL financial data is available for this company yet.

Calendar-year figures as reported to the SEC in XBRL filings.

Recent SEC filings

• 6-KREPORT OF FOREIGN PRIVATE ISSUER2026-10-05
• 6-KREPORT OF FOREIGN PRIVATE ISSUER2026-09-09
• 6-KREPORT OF FOREIGN PRIVATE ISSUER2026-09-02
• 6-KREPORT OF FOREIGN PRIVATE ISSUER2026-08-10
• 6-KREPORT OF FOREIGN PRIVATE ISSUER2026-08-07
• 6-KREPORT OF FOREIGN PRIVATE ISSUER2026-07-29
• 6-KREPORT OF FOREIGN PRIVATE ISSUER2026-06-23
• 6-KREPORT OF FOREIGN PRIVATE ISSUER2026-06-11
• 6-KREPORT OF FOREIGN PRIVATE ISSUER2026-05-15
• 6-KREPORT OF FOREIGN PRIVATE ISSUER2026-04-27
• 6-KREPORT OF FOREIGN PRIVATE ISSUER2026-04-23
• 6-KREPORT OF FOREIGN PRIVATE ISSUER2026-03-25

About Purple Biotech Ltd.

Ticker

PPBT (Nasdaq)

Industry

Pharmaceutical Preparations

Headquarters

Rehovot, Israel

Incorporated in

Israel

Fiscal year end

December 31

SEC CIK

1614744

Former names

Kitov Pharma Ltd., Kitov Pharmaceuticals Holdings Ltd.

Frequently asked questions